Device Trial Radar · NCT02286739
Prospective Clinical Study Evaluating Tibiofemoral Rotational Alignment Using Intraoperative Sensing During Total Knee Arthroplasty (TKA)
Last checked: Nov 20, 2026Latest source record: Aug 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
500
Actual
Start
Apr 2015
Primary completion
May 2020
Study completion May 2020
Sponsor
- Lead sponsor
- Orthosensor, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 10, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Basic science
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objectives of the study are twofold: 1) Evaluate how intra-operative sensing may assist the surgeon with tibiofemoral rotational alignment by testing the precision and variability of setting tray rotation to the mid-third of the tibial tubercle. 2) Understand if patients with a combined axial rotation couple at the tibiofemoral joint and quantitative intercompartmental balance, achieved with the use of VERASENSE, exhibit less post-operative knee pain and improved clinical outcomes. Radiographic outcomes will also be assessed to measure post-operative alignment and to evaluate the prevalence and location of radiolucency and/or osteolysis.
Conditions
- Osteoarthritis
Interventions
TKA with "Verasense"Device
VERASENSE replaces the standard tibial trial inserts and is embedded with microelectronics and sensors to provide surgeons with real-time knee kinetic data. The data is wirelessly transmitted to a graphic display (VERASENSE Knee Application), allowing surgeons to quantify and assess soft tissue intercompartmental loads throughout the range of motion. The VERASENSE sensor is not an investigational device. OrthoSensor, Inc., received FDA pre-market submission (510K) clearance in 2009. The indication for use is a tool for adjustment of the femoral knee implant to reduce instability from flexion gap asymmetry. The VERASENSE sensor is sterile and single patient use.
TKA without "Verasense"Procedure
TKA will be performed manually without the use of Verasense
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Quantitatively Balanced and Unbalanced Knees in Primary Unilateral Total Knee ArthroplastyTime frame: Intra-operative with trial implants in place and after completing all surgical corrections.
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
The Cleveland Clinic Foundation
Weston, Florida
Emory University
Atlanta, Georgia
Illinois Bone & Joint Institute
Morton Grove, Illinois
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.